Manufacturers Life Insurance Company, The Syros Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $102 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022
SELL
$1.02 - $3.8 $36,505 - $136,002
-35,790 Closed
0 $0
Q4 2021

Feb 16, 2022
BUY
$3.26 - $4.66 $5,036 - $7,199
1,545 Added 4.51%
35,790 $117,000
Q3 2021

Nov 12, 2021
SELL
$4.08 - $5.66 $9,335 - $12,950
-2,288 Reduced 6.26%
34,245 $153,000
Q2 2021

Aug 12, 2021
BUY
$5.01 - $7.48 $40,721 - $60,797
8,128 Added 28.61%
36,533 $199,000
Q1 2021

May 03, 2021
BUY
$7.19 - $14.95 $16,723 - $34,773
2,326 Added 8.92%
28,405 $212,000
Q4 2020

Feb 12, 2021
BUY
$6.66 - $14.66 $5,441 - $11,977
817 Added 3.23%
26,079 $283,000
Q2 2020

Aug 10, 2020
BUY
$5.21 - $11.03 $10,925 - $23,129
2,097 Added 9.05%
25,262 $266,000
Q1 2020

May 15, 2020
BUY
$4.46 - $9.2 $7,269 - $14,995
1,630 Added 7.57%
23,165 $137,000
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $4,917 - $10,988
-1,088 Reduced 4.81%
21,535 $149,000
Q3 2019

Nov 12, 2019
SELL
$7.14 - $11.65 $7,425 - $12,116
-1,040 Reduced 4.4%
22,623 $236,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $74,101 - $131,361
13,473 Added 132.22%
23,663 $219,000
Q1 2019

May 13, 2019
BUY
$5.51 - $9.59 $56,146 - $97,722
10,190 New
10,190 $93,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $57,509 - $117,505
-10,362 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$9.74 - $12.92 $98,081 - $130,104
-10,070 Reduced 49.29%
10,362 $123,000
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $76,301 - $102,511
7,510 Added 58.12%
20,432 $208,000
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $91,773 - $125,789
9,691 Added 299.94%
12,922 $168,000
Q4 2017

Feb 08, 2018
SELL
$8.45 - $17.48 $30,724 - $63,557
-3,636 Reduced 52.95%
3,231 $32,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $92,841 - $163,091
6,867
6,867 $101,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email